| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0006-291X(05)80184-6 |
| P698 | PubMed publication ID | 2222463 |
| P50 | author | John Vane | Q309971 |
| P2093 | author name string | J A Mitchell | |
| W C Sessa | |||
| M Hecker | |||
| T A Swierkosz | |||
| P2860 | cites work | Vascular endothelial cells synthesize nitric oxide from L-arginine | Q28291036 |
| THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD | Q41413567 | ||
| L-NG-nitro arginine (L-NOARG), a novel, L-arginine-reversible inhibitor of endothelium-dependent vasodilatation in vitro | Q42140081 | ||
| Vasorelaxant properties of the endothelium-derived relaxing factor more closely resemble S-nitrosocysteine than nitric oxide | Q42478033 | ||
| Arginine is a physiological precursor of endothelium-derived nitric oxide | Q42516066 | ||
| The generation of L-arginine in endothelial cells is linked to the release of endothelium-derived relaxing factor | Q43672593 | ||
| Endothelial cells metabolize NG-monomethyl-L-arginine to L-citrulline and subsequently to L-arginine | Q43714355 | ||
| Depletion of arterial L-arginine causes reversible tolerance to endothelium-dependent relaxation. | Q50885317 | ||
| Cultured endothelial cells maintain their L-arginine level despite the continuous release of EDRF | Q68581725 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 143-148 | |
| P577 | publication date | 1990-10-01 | |
| P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
| P1476 | title | L-glutamine inhibits the release of endothelium-derived relaxing factor from the rabbit aorta | |
| P478 | volume | 172 |
| Q57793083 | Citrulline Generation Test: What Does It Measure? |
| Q47586008 | Effects of glutamine and hyperoxia on pulmonary oxygen uptake and muscle deoxygenation kinetics. |
| Q73479876 | Effects of nitric oxide-modulating amino acids on coronary vessels: relevance to sepsis |
| Q36622844 | Evidence that links loss of cyclooxygenase-2 with increased asymmetric dimethylarginine: novel explanation of cardiovascular side effects associated with anti-inflammatory drugs |
| Q61412054 | Glutamine metabolism in endothelial cells: ornithine synthesis from glutamine via pyrroline-5-carboxylate synthase |
| Q28345516 | Glutamine metabolism to glucosamine is necessary for glutamine inhibition of endothelial nitric oxide synthesis |
| Q34775724 | Glutamine supplementation alleviates vasculopathy and corrects metabolic profile in an in vivo model of endothelial cell dysfunction |
| Q35742043 | Glutamine-dependent inhibition of pial arteriolar dilation to acetylcholine with and without hyperammonemia in the rat |
| Q37403725 | Ibuprofen arginate retains eNOS substrate activity and reverses endothelial dysfunction: implications for the COX-2/ADMA axis. |
| Q42920440 | Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors |
| Q41950416 | Inhibition of the release of endothelium-derived relaxing factor in vitro and in vivo by dipeptides containing NG-nitro-L-arginine |
| Q42277909 | Preservation of Cerebral Blood Flow Responses to Hypoxia and Arterial Pressure Alterations in Hyperammonemic Rats |
| Q39490913 | Relative contribution of different l-arginine sources to the substrate supply of endothelial nitric oxide synthase |
| Q43263261 | Role of L-citrulline transport in nitric oxide synthesis in rat aortic smooth muscle cells activated with LPS and interferon-gamma |
| Q42712440 | Selective impairment of hindquarters vasodilator responses to bradykinin in conscious Wistar rats with streptozotocin-induced diabetes mellitus |
| Q39302506 | The Roles of Glutamine in the Intestine and Its Implication in Intestinal Diseases |
Search more.